Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Development of androgen receptor antagonists with promising activity in castration-resistant prostate cancer.

Development of androgen receptor antagonists with promising activity in castration-resistant prostate cancer. Cancer Cell. 2009 Jun 02; 15(6):461-3.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.